Bioventus launches biphasic bone graftMarch 5, 2019
Bioventus has launched Osteomatrix+, a biphasic bone graft for use in bone remodelling in a variety of orthopaedic and spine applications.
Osteomatrix+ is a moldable bone graft substitute consisting of bovine collagen and biphasic hydroxyapatite/ß-tricalcium phosphate granules
designed to produce a reliable, porous scaffold and sustained osteoconductivity throughout the bone remodeling process.
Osteomatrix+ has more unique handling properties, including improved moldability, flexibility and versatility, than its predecessor, according to the company.
Bioventus’ portfolio includes offerings for osteoarthritis, surgical and non-surgical bone healing.